The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Rank |
|---|---|---|---|---|---|
Valuation | 35 | 27.7x | 20.8x | Bottom tier | |
Growth | 50 | 9.1% | 6.1% | Around median | |
Quality | 75 | 16.6% | 6.6% | Top tier | |
Safety | 68 | 0.8x | 0.7x | Top tier | |
Capital Return | 43 | 0.73% | 2.02% | Around median | |
Momentum | 53 | 9.4% | 4.1% | Around median | |
Sentiment | 60 | 11 | 3 | Around median |
Estimates — analyst targets and a simplified DCF, not investment advice.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.
Agilent Technologies, Inc. (NYSE: A) is active in providing analytical solutions, instruments, and services to life sciences, diagnostics, and applied markets globally. The company generates its revenues through three main operating segments: the Applied Markets Group (AMG), the Life Sciences and Diagnostics Group (LDG), and the Agilent CrossLab Group (ACG). In the second quarter of fiscal year 2026, the company achieved strong results, with total revenues reaching $1.83 billion, representing core growth of 6.3% compared to the previous year, which exceeded the upper limit of the company's guidance by 80 basis points thanks to broad momentum in its major end markets.
On the profitability front, the company recorded a gross margin of 55.0%, an increase of 90 basis points, and a strong operating margin of 26.4%, up 130 basis points year-over-year, supported by Ignite operating system savings and positive operating leverage. Regarding segment performance, the AMG segment achieved 11% growth driven by strong demand for mass spectrometry instruments in the semiconductor sector, while the LDG segment grew by 9% thanks to sales of liquid chromatography instruments and the Omnis diagnostics product family, while the ACG segment grew by 2%. In the first quarter of 2026 (according to quarterly reports filed with the Securities and Exchange Commission), the company recorded revenues of $1.8 billion, net income of $305.0 million, and earnings per share of $1.07.
Analysts hold a consensus Buy recommendation for Agilent Technologies, Inc. stock, with an average price target of $154.75, a high target of $165, and a low target of $140. The stock is currently trading within a 52-week range of $108.35 to $160.27, which positions the trading price below the analysts' average price target. This valuation reflects cautious optimism given the P/E ratio and the adjusted earnings growth outlook for the full fiscal year of 7% to 9%.
Figures in the text are as of 2026-06-15; the live price is shown at the top of the page.
Agilent signed a contract with a total value of $9 million with the US Transportation Security Administration (TSA) to supply its new bulk material alarm resolution technology at airport security checkpoints. This advanced technology will be deployed in US host cities for the 2026 FIFA World Cup to screen large volumes of liquids, powders, and solids. The company successfully recognized $5 million of this contract's value during the second quarter of fiscal year 2026, with the implementation process proceeding excellently.
The Ignite operating system plays a pivotal role in enhancing Agilent's operational and structural efficiency, contributing to a strategic pricing realization of 200 basis points during the second quarter, exceeding the annual target of 100 basis points. This system also enabled the company to fully mitigate the impact of additional tariffs through manufacturing moves and targeted pricing adjustments. Furthermore, AI tools integrated into supply chains via the Ignite system helped improve delivery lead times and reduce overall manufacturing costs by more than 50 basis points compared to last year.
Agilent unveiled a range of notable innovations, led by the 9.5 thousand triple quad ICPMS instrument for mass spectrometry, which reduces workflow complexity and operational costs through a patented dual-cell system. The company also launched a new version of its unified software, OpenLab CDS Version 3.0, to support high-resolution chromatography and mass spectrometry analysis. Additionally, the company introduced upgraded gas chromatography instruments featuring up to 30% faster oven cooling and advanced technologies for conserving or replacing helium gas.
Automated analysis for informational purposes only — not investment advice.
Agilent raised its financial guidance for the full fiscal year 2026 based on strong second-quarter performance; it now expects core revenue growth of 4.5% to 6.0%, bringing reported revenues to between $7.39 billion and $7.49 billion. The company also raised its guidance for diluted earnings per share to a range of $6.00 to $6.10, representing earnings growth of 7% to 9%. The company also expects operating cash flow to range between $1.2 billion and $1.7 billion, with approximately $450 million invested in capital expenditures.
Despite a 9% decline in China revenues in the second quarter due to the timing of Chinese New Year and delayed government funding, first-half performance was flat and aligned with full-year expectations. The company remains strongly committed to the Chinese market, where it launched the China Innovation Center to bolster R&D capabilities in AI and digital automation. Management expects the impact of Chinese government stimulus to begin showing as orders at the end of the current year, translating into actual revenues in early fiscal year 2027.